Quick search:
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Vaccine rollout: Remember those with Type 1 diabetes
2 Mendelian Randomization Study Shows Vitamin D Deficiency Not Associated With T1D
3 GWAS Shows Vitamin D Deficiency Not Associated With T1D
4 Immune response to insulin could identify, help treat those at risk for Type 1 Diabetes
5 Black Patients With T1D and COVID-19 Face Added Risk of Diabetic Ketoacidos
6 Tidepool Loop app FDA approval launches future of type 1 diabetes care
7 Study: Children with Type 1 diabetes have lower brain volume, verbal IQ, and overall IQ
8 Toxic Relationships and Type 1 Diabetes
9 T1D Inspiration: Running the Alps on Keto
10 Ophthalmologic Care Crucial for Women With T1D Before and During Pregnancy
11 We Can Thank This Researcher with Type 1 Diabetes for the COVID-19 Vaccines
12 Type 1 diabetes doesn’t qualify for Massachusetts coronavirus vaccine priority, but Type 2 does
13 Study: Immune Response to Insulin Could Identify, Help Treat Those at Risk for Type 1 Diabetes
14 ViaCyte Announces Initiation of Phase 2 Study of Encapsulated Cell Therapy for Type 1 Diabetes Patients
15 FDA Green Lights Trials of New Type 1 Diabetes Stem Cell Therapy
16 How are the CDC, North Carolina treating Type 1 diabetes in the vaccine rollout?
17 Experimental treatment appears to subdue type 1 diabetes in laboratory mice
18 JDRF Announces New Center of Excellence in New England to Advance Type 1 Diabetes Research
19 Clinical trial to test treatment for recent onset Type 1 Diabetes
20 Vitamin D deficiency does not increase risk of type 1 diabetes, study finds
21 vTv Therapeutics Announces Publication in Diabetes Care of Results from SimpliciT-1 Study of TTP399 in Patients with Type 1 Diabetes
22 Letter to the editor: A partnership to defeat Type 1 diabetes, the furniture industry and City of Hope
23 A Glimpse to the future: Helping kids with type 1 diabetes
24 New clinical study aims to prevent type 1 diabetes in children
25 Global Type 1 Diabetes (T1D) Market 2020 Strategic Growth, Key Manufacturers and Industry Demand Analysis to 2025 – FLA News
26 Real Steps to Combat Racial Disparities in Diabetes Care
27 Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes
28 Mass. doctor on why Type 1 diabetes isn't on Mass. co-morbidities list
29 Eye imaging may reveal cognitive dysfunction risk in type 1 diabetes
30 New tech brings hope for parents, children living with Type 1 Diabetes
31 Time in Range Does Not Associate With Carotid Artery Wall Thickness and Endothelial Function in Type 1 Diabetes
32 High Glucose in Kids With Type 1 Diabetes 'Noxious to the Brain'
33 CoxHealth advocates for Type 1 diabetes patients to be added to Phase 1B of COVID-19 vaccination plan
34 Fact check: Johnston County billboard slams Cooper over 'Type 1 diabetes'
35 Low Carb Dinners for Type 1 Diabetes Made Easy
36 Provention Bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
37 Coronavirus vaccine: Not all diabetics are equal under Pennsylvania vaccination protocols
38 JDRF, Lupus Research Alliance and National Multiple Sclerosis Society join forces to decode common m
39 Aerobic exercise best for reducing delayed hypoglycemia risk in type 1 diabetes
40 NBA Hall of Famer Ray Allen on managing his son's Type 1 diabetes during COVID-19
41 Hepatoselective glucokinase activator shows early promise in type 1 diabetes
42 FDA clears IND application for stem cell therapy to treat type 1 diabetes
43 Impact of COVID-19 lockdown on glucemic control in children and adolescents with type 1 diabetes mellitus
44 The Terrifying Story of How Ray Allen's Young Son's Type 1 Diabetes Was Almost Misdiagnosed
45 Type 1 diabetes and children: PADRE Foundation in Orange County helps SoCal families physically and mentally
46 Diagnosis and management of type 1 diabetes mellitus
47 Vaccine rollout: Beware quick judgment
48 Type 1 Diabetes (T1D) Market Size 2021 | Driving Factors by Manufacturers – Novo Nordisk, Astellas, Merck, Sanofi, Biocon – The Bisouv Network
49 Experimental mAb subdues type 1 diabetes in laboratory mice
50 Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific Meeting
51 Glucagon Receptor Blockade Promotes Recovery of Functional β-Cell Mass in Diabetic Mice
52 Celebrating the discovery and development of insulin | NIDDK
53 Sotagliflozin with Insulin therapy prevents DKA in young Type 1 Diabetics: Study
54 Provention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q4 2020 Results
55 Flexible Insulin Therapy in Physically Active Adults with Type-1 Diabetes
56 A Life Well Lived with 'Complications' of Diabetes
57 Polyvaccine: joining the links in the cascade of type 1 diabetes
58 In pandemic, early signs of childhood diabetes may be missed, expert warns
59 University of Alberta researchers developing Type 1 diabetes cure
60 Edited Transcript of PRVB.OQ earnings conference call or presentation 25-Feb-21 1:00pm GMT
61 Type 1 Diabetes Market Detailed Study Mentioning Positive Growth | Players – Novo Nordisk, Astellas, Merck. – KSU | The Sentinel Newspaper
62 Type 1 Diabetes (T1D) Market: Facts, Figures and Analytical Insights, 2020 to 2027 – Express Keeper
63 Precision Medicine Approach Reverses Case of Type 1 Diabetes
64 Tiziana Life Sciences Interview to Air on Bloomberg Television US on The RedChip Money Report
65 Early-Onset T1DM Negatively Impacts Brain Development Over Time
66 JDRF Celebrates the Strength of the Type 1 Diabetes Community with the "Power of Us" Campaign for National Diabetes Awareness Month
67 Jaguar primed to pounce with portfolio of early stage gene therapies
68 For people with type 1 diabetes, CDC Covid guidelines are puzzling
69 Type 1 diabetes is less common, and misconceptions abound. Here are five.
70 Artificial pancreas effectively controls type 1 diabetes in children age 6 and up
71 Global Type 1 Diabetes Treatment Market is Thriving According to New Report: Opportunities Rise For Stakeholders by 2026 – NeighborWebSJ
72 Black Americans With T1D, COVID-19 Have Increased Risk of Hospitalization for DKA
73 vTv Therapeutics Announces 2020 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
74 A New Home Testing Kit Screens for Type 1 Diabetes
75 COVID-19 Vaccine Priority Should Include Type 1 Diabetes
76 Market Assessment of Type 1 Diabetes Drugs Industry including Top Players like Novo Nordisk, Sanofi, Eli Lily, Adocia, Astellas Pharma, AstraZeneca, and more | Affluence – The Bisouv Network
77 Analysis: Is the COVID-19 vaccine safe for people with Type 1 diabetes?
78 Do I Qualify? Vaccine Confusion For Patients With Multiple Serious Medical Conditions
79 Penn study proves promising for type 1 diabetes cure
80 Parental Knowledge of Type 1 Diabetes Risk Appears to Lower Ketoacidosis Risk
81 Is There a Vaccine for Type 1 Diabetes?
82 First case of Type 1 diabetes reversal using precision medicine
83 Odds for DKA higher for Black patients with type 1 diabetes, COVID-19
84 JDRF Launches First Mass Screening Program for Early-Stage Type 1 Diabetes (T1D) Detection
85 Type 1 Diabetes Market to 2027 – Abbott, Bayer, Eli Lilly and Others
86 Nisus CEO, wife to lead foundation for type 1 diabetes research
87 The beginning of the end for Type 1 diabetes: A new view from immunotherapy science
88 Could COVID-19 Cause New Onset T1D?
89 Preventing Type 1 diabetes by targeting a T-cell protein
90 Insulin-Producing Cells May Last Longer in People With Type 1 Diabetes
91 Impact of COVID-19 on Type-1 Diabetes Treatment Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2027 | Astellas Pharma, Merck, Eli Lilly, Novo Nordisk – NeighborWebSJ
92 Maryland Teen Designs App To Help Families Dealing With Type 1 Diabetes
93 Developing an 'Inverse Vaccine' for Type 1 Diabetes
94 Health advocates warn Minnesota's COVID-19 vaccine priorities ignore high-risk individuals
95 The SimpliciT1 study: A randomized, double-blind, placebo-controlled phase 1b/2 adaptive study of TTP399, a hepatoselective glucokinase activator, for adjunctive treatment of type 1 diabetes
96 Growing Old with Type 1 Diabetes: Problems and Solutions
97 St. Albans teen advocating proposed bill to lower diabetic supply costs
98 $14 Million Push for Type 1 Diabetes Breakthroughs: New JDRF Center of Excellence at the University of Michigan
99 Hospitalization Risk Four Times Higher in Blacks With T1D, COVID-19
100 At the Oklahoma Legislature | News |